researcher author publish-with-us 
Rethinking Clinical Trials
AUGUST 17, 2023
When research and clinical care are deliberately integrated in an embedded pragmatic clinical trial, the nature and extent of investigators’ obligations to patient-subjects are blurred, as is the clinician’s duty to participate is such research. Some of the responses to the target articles are highlighted below.
Pharmaceutical Technology
MARCH 23, 2023
These changes come following a public consultation with the Healthcare Research Authority, to which a government response was published on March 21. Furthermore, the UK is now implementing a legislative requirement to publicly register clinical trials and share summary results with any research participants.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
JANUARY 31, 2023
The authors suggest that for data to be useful for new generative science or for reproducibility, the NIH should provide guidance regarding 5 important questions: What data should be shared and for what purpose? For more, read the full article , and see the Living Textbook chapter on Data Sharing and Embedded Research.
World of DTC Marketing
DECEMBER 2, 2021
The FDA wrote, “the researchers concluded that drug companies who create drug advertisements, as well as regulators who are responsible for reviewing promotional material, should pay special attention to ensuring that images accurately reflect drug efficacy.” Higher numeracy was associated with better gist and verbatim recall.”
pharmaphorum
SEPTEMBER 5, 2022
Greater use of telehealth services forced by COVID-19 seems to have benefitted people with opioid use disorder (OUD), leading to longer times on treatment and reduced risk of overdose, according to a new study. The authors say that the finding “lends support for permanently implementing access to telehealth services.”
Drug Discovery World
JANUARY 8, 2024
A novel antibiotic class targeting a major global pathogen and threat to human health has been discovered by scientists from Roche and Harvard University (Cambridge, MA, US). Low market incentives In July 2023, a report by University of Queensland (UQ) researchers warned that a global crisis of antibiotic resistance is inevitable.
WCG Clinical
APRIL 20, 2023
Published by the Journal for Clinical Studies Volume 15 Issue 1 Mar 30, 2023 The imperative to obtain a diverse body of clinical trial participants has been stressed in public statements for decades; however, parties executing clinical trials have remained insufficiently effective in addressing it. appeared first on WCG Clinical.
Expert insights. Personalized for you.
130 
Let's personalize your content